The EU-Startups Podcast | How European BioTech is changing cancer care – Roundtable special
The Women TechEU Roundtable episode features founders from Alga Biologics, Allogenica, and InFocus Therapeutics discussing how to move breakthrough cancer research from laboratory to patients. The conversation covers sustainable microalgae-based antibody production, scalable allogeneic cell therapies, and generative chemistry for RNA drug targeting. Participants highlight Europe's strengths in research but note funding, infrastructure, and ecosystem challenges for scaling BioTech ventures.
Key points
- Three French founders building next-generation cancer therapies via microalgae manufacturing, T-cell therapies, and AI-driven RNA drug design
- Europe excels at research but faces friction in funding and scaling BioTech companies
- Focus on moving personalized treatments to scalable, off-the-shelf solutions for broader patient reach
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. EU-Startups did the reporting; read the original for the full story.
Read the full story at EU-Startups
